Terms: = Head and neck cancer AND MUC16, CA125, CA-125 AND Prognosis
9 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Ca 125 is an independent prognostic marker in resected pancreatic cancer of the head of the pancreas.
Napoli N; Kauffmann EF; Ginesini M; Lami L; Lombardo C; Vistoli F; Campani D; Boggi U
Updates Surg; 2023 Sep; 75(6):1481-1496. PubMed ID: 37535191
[TBL] [Abstract] [Full Text] [Related]
3. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.
Ju G; Yao Z; Zhao Y; Zhao X; Liu F
Sci Rep; 2023 Jun; 13(1):10020. PubMed ID: 37340028
[TBL] [Abstract] [Full Text] [Related]
4.
Alamri AM; Alkhilaiwi FA; Khan NU; Tasleem M
Anticancer Agents Med Chem; 2023; 23(19):2111-2126. PubMed ID: 37287303
[TBL] [Abstract] [Full Text] [Related]
5. Comprehensive genomic analysis of primary malignant melanoma of the esophagus reveals similar genetic patterns compared with epithelium-associated melanomas.
Li J; Liu B; Ye Q; Xiao X; Yan S; Guan W; He L; Wang C; Yu Z; Tai Z; Pei S; Ma Y; Li S; Wang Y; Wu N
Mod Pathol; 2022 Nov; 35(11):1596-1608. PubMed ID: 35688970
[TBL] [Abstract] [Full Text] [Related]
6. Dynamics of Serum Tumor Markers Can Serve as a Prognostic Biomarker for Chinese Advanced Non-small Cell Lung cancer Patients Treated With Immune Checkpoint Inhibitors.
Zhang Z; Yuan F; Chen R; Li Y; Ma J; Yan X; Wang L; Zhang F; Tao H; Guo D; Huang Z; Zhang S; Li X; Zhi X; Ge X; Hu Y; Wang J
Front Immunol; 2020; 11():1173. PubMed ID: 32587591
[No Abstract] [Full Text] [Related]
7. Clinical significance of preoperative serum tumor markers in esophageal squamous cell carcinoma.
Zhao H; Chen W; Wu J; Wang L; Mao W
J Cancer Res Ther; 2014 Nov; 10 Suppl():C179-85. PubMed ID: 25450279
[TBL] [Abstract] [Full Text] [Related]
8. Cytokeratin fragments in the serum: their utility for the management of oral cancer.
Sawant SS; Zingde SM; Vaidya MM
Oral Oncol; 2008 Aug; 44(8):722-32. PubMed ID: 18203649
[TBL] [Abstract] [Full Text] [Related]
9. Relevance of SCC-Ag, CEA, CA 19.9 and CA 125 for diagnosis and follow-up in oral cancer.
Krimmel M; Hoffmann J; Krimmel C; Cornelius CP; Schwenzer N
J Craniomaxillofac Surg; 1998 Aug; 26(4):243-8. PubMed ID: 9777503
[TBL] [Abstract] [Full Text] [Related]